Encouraging Results for Multiple Sclerosis Treatment
Links shared publicly online about this topic.
- 1,121total visits
Encouraging Results for Multiple Sclerosis Treatment
View full resource at disabled-world.com
Tags: Multiple Sclerosis, Disease and Condition, Scientist
Most Recently Shared on June 3, 2010 at 2:19 pm By:
Encouraging Results for Multiple Sclerosis Treatment http://ff.im/-lpfPb
Laquinimod trial results published | News | MS Trust - Information, education, research and support
mstrust.org.uk — “Latest news about multiple sclerosis from the MS Trust” View full resource at mstrust.org.uk
Most Recently Shared on March 16, 2012 at 1:08 am By:
Laquinimod trial results published: Laquinimod, a potential oral treatment for relapsing remitting MS, has a mod... http://t.co/tc27FE3B
New treatment for Multiple Sclerosis: Cambridge University translates research at the bench into a drug at the bedside
medicalxpress.com — “The culmination of three decades of research in Cambridge has resulted in the exciting prospect of a new transformational treatment for multiple sclerosis.” View full resource at medicalxpress.com
Most Recently Shared on November 15, 2011 at 4:43 pm By:
New treatment for Multiple Sclerosis: Cambridge University translates research at the bench into a drug at the b... http://t.co/HHDse4dk
Acute Multiple Sclerosis - H.P. Acthar® Gel Reduces Shows Promise In Acute Exacerbations
medicalnewstoday.com — “A presentation at the American Society of Nephrology 44th Annual Meeting, showed study results of H.P. Acthar® Gel, a natural adrenocorticotropic hormone (ACTH) designed for treatment of acute” View full resource at medicalnewstoday.com
Most Recently Shared on November 13, 2011 at 8:05 am By:
Acute Multiple Sclerosis - H.P. Acthar® Gel Reduces Shows Promise In Acute Exacerbations http://t.co/2ygfEhTK #multiplesclerosis
National Health Council: MODDERN Cures Solution
puttingpatientsfirst.net — “National Health Council: MODDERN Cures Solution” View full resource at puttingpatientsfirst.net
Most Recently Shared on November 12, 2011 at 2:25 pm By:
Nat. Health Council Health Organization
Ensure that science, not patent law, drives the development of new therapies w/ creation of #dormant-therapies http://t.co/gUnvRjH4 #MODDERN
Biogen, Abbott tout promising MS data from PhIIb daclizumab trial - FierceBiotech
fiercebiotech.com — “Biogen Idec and its partner Abbott Labs have taken the wraps off the top-line data from a Phase IIb study of daclizumab, touting some promising results for the once-monthly treatment of multiple Read more...” View full resource at fiercebiotech.com
Most Recently Shared on August 10, 2011 at 1:44 pm By:
ScienceintheTriangle Science Enthusiast
Biogen, Abbott tout promising MS data from phase II trial. (FierceBiotech) http://bit.ly/o8idiS #SITT
Phase 3 Study of Laquinimod for Multiple Sclerosis - MPR
empr.com — “Teva Pharmaceuticals Industries Ltd. announced initial results from its Phase 3 BRAVO study of laquinimod for the treatment of multiple sclerosis (MS).” View full resource at empr.com
Most Recently Shared on August 1, 2011 at 3:01 pm By:
MPR News: Phase 3 Study of Laquinimod for Multiple Sclerosis: Teva Pharmaceuticals Industries Ltd. announced ini... http://bit.ly/qV46XI
Results of Phase III BRAVO Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment - Drugs.com MedNews
drugs.com — “Primary endpoint of reducing annualized relapse rate was not statistically achieved Following a standard adjustment, in accordance with a pre-defined sensitivit” View full resource at drugs.com
Most Recently Shared on August 1, 2011 at 12:10 pm By:
Drugs and Devices OW OW Health
Results of Phase III BRAVO Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment: ... http://bit.ly/p0P7ob #drug
[Budget impact analysis of the first-line treatmen... [Rev Neurol. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on July 15, 2011 at 5:58 am By:
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain.]: CONCLU... http://bit.ly/omCxcs
Phase 3 Study of Lemtrada for Multiple Sclerosis - ONA
oncologynurseadvisor.com — “Sanofi and Genzyme announced results from its CARE-MS 1 study of Lemtrada (alemtuzumab) for the treatment of multiple sclerosis.” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 11, 2011 at 2:34 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 Study of Lemtrada for Multiple Sclerosis http://goo.gl/fb/mUQp3
Phase 3 Study of Lemtrada for Multiple Sclerosis - MPR
empr.com — “Sanofi and Genzyme announced results from its CARE-MS 1 study of Lemtrada (alemtuzumab) for the treatment of multiple sclerosis.” View full resource at empr.com
Most Recently Shared on July 11, 2011 at 2:17 pm By:
MPR News: Phase 3 Study of Lemtrada for Multiple Sclerosis: Sanofi and Genzyme announced results from its CARE-M... http://bit.ly/qD2Spz
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sclerosis - Drugs.com MedNews
drugs.com — “- 55 percent relapse rate reduction over and above high dose IFN -1a in treatment na ve MS patients - Jul 11, 2011 - Sanofi (EURONEXT SAN and NYSE SNY) and its” View full resource at drugs.com
Most Recently Shared on July 11, 2011 at 2:10 pm By:
Drugs and Devices OW OW Health
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sc... http://bit.ly/rh0CHK #drug
Sanofi MS drug shines, biotech strategy advances - FierceBiotech
fiercebiotech.com — “Sanofi is seeing its increased focus on biotech drugs go according to plan, with positive results today from a late-stage trial of a multiple sclerosis treatment, Lemtrada, which the French drugmaker Read more...” View full resource at fiercebiotech.com
Most Recently Shared on July 11, 2011 at 1:21 pm By:
Sanofi MS drug shines, biotech strategy advances. http://bit.ly/ov68ZD
Neurology Article | Multiple Sclerosis
mdlinx.com — “Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment” View full resource at mdlinx.com
Most Recently Shared on May 27, 2011 at 4:50 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizu... http://bit.ly/lrhqmK #neuro
Phase 3 Study of Laquinimod for Multiple Sclerosis - MPR
empr.com — “Teva Pharmaceutical and Active Biotech announced results from their Phase 3 ALLEGRO study of laquinimod for the treatment of relapsing forms of multiple sclerosis (MS).” View full resource at empr.com
Most Recently Shared on April 13, 2011 at 9:03 pm By:
MPR News: Phase 3 Study of Laquinimod for Multiple Sclerosis: Teva Pharmaceutical and Active Biotech announced r... http://bit.ly/gSko8n
Phase 3 Study of Laquinimod for Multiple Sclerosis - ONA
oncologynurseadvisor.com — “Teva Pharmaceutical and Active Biotech announced results from their Phase 3 ALLEGRO study of laquinimod for the treatment of relapsing forms of multiple sclerosis (MS).” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 13, 2011 at 8:48 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 Study of Laquinimod for Multiple Sclerosis http://goo.gl/fb/Y72JP
Advertisement
